Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Dear Editor, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that causes Coronavirus Disease 2019 (COVID-19) (Yang and Wang, 2020), has spread to more than 200 countries and infected more than 9,000,000 people as of Jun 2020. Tens of thousands of patients with COVID-19 have recovered and been discharged from hospital. However, there are reports of recovered patients who subsequently tested positive for SARS-CoV-2 after discharge (re-detectable positive, RP) (An et al., 2020; Lan et al., 2020), and this has led to increasing focus on the mechanism(s) underlying RP. Several studies of discharged patients have been performed to investigate the proportion of RP and the clinical symptoms of these patients (An et al., 2020; Lan et al., 2020). One study revealed that four patients had positive SARS-CoV-2 RT-PCR tests 5 to 13 days after discharge (Lan et al., 2020), while a retrospective study in Wuhan, China reported that 8/108 (7.4%) patients were RP (Cao et al., 2020). Moreover, 14.5% of convalescent patients (n = 38) were RP for SARS-CoV-2 RNA in RT-PCR tests of both anal and nasopharyngeal swabs (An et al., 2020). RP is usually observed in young patients who had mild or moderate COVID-19 symptoms on the first admission, and several significant characteristic features including early RNA-negative conversion, fewer comorbidities, and more frequent upper respiratory symptoms (An et al., 2020). No obvious clinical symptoms were reported on the second admission of these patients (An et al., 2020; Lan et al., 2020; Cao et al., 2020). In recent reports, close contacts of RP patients were tested negative for SARS-CoV-2 RNA (An et al., 2020; Lan et al., 2020). However, as the patients were usually in quarantine after discharge, the infectivity of the patients might be underestimated. Two patients who were RP continued to be positive for SARS-COV-2 RNA for more than 90 days (Cao et al., 2020). Careful consideration should therefore be given to the potential for patients who are RP to become chronic virus-carriers. The cause of RP remains controversial, and consequently it is difficult to set standards for discharge and follow-up of patients. False negatives in qRT-PCR tests may partially explain the RP in some cases, because the lower limit of detection (LOD) of commercial RT-PCR kits is relatively high (An et al., 2020). The residual viremia could be another factor that leads to RP. Pathological examination of a ready-for-discharge patient who had COVID-19 identified viral particles in the pneumocytes. Several studies have reported the presence of SARS-CoV-2 RNA and viral particles in the gastrointestinal tracts of patients who had COVID-19, and that fecal samples remained viral RNA-positive after patients were respiratory-negative for SARS-CoV-2 and were discharged from hospital (Xu et al., 2020), thus highlighting the prolonged presence of SARS-CoV-2 in the gastrointestinal tract. Here, we investigated whether the intestine might be a “reservoir” of SARS-CoV-2 and one of the potential causes of RP. Between January 21 and March 8, 2020, a total of 173 patients who had COVID-19 were discharged from hospitals in Hefei, China, including the First Affiliated Hospital of University of Science and Technology of China (USTC). The patients were enrolled in this study for analysis of clinical parameters, and were followed for at least one month. During the monitoring, 12 out of 173 patients were found to be RP (Table S1). All 12 of these patients had gastrointestinal symptoms, including nausea, diarrhea, anorexia, abdominal pain and belching (Table S2), and three out of those patients who were RP developed a gastrointestinal symptom as the onset symptom (Table S2). In contrast to the reported 2%–39% of patients with COVID-19 who develop gastrointestinal symptoms (Chen et al., 2020; Zhang et al., 2020; Zheng et al., 2020), patients who were RP in Hefei had a much higher incidence of gastrointestinal symptoms (P-value < 2.2 × 10−16 by Chi-squared contingency table test). Patient G developed a fever and diarrhea over 3 days from January 28, 2020, was confirmed to have COVID-19 on February 4, and was then transferred to the intensive care unit (ICU) of the First Affiliated Hospital of USTC as a severe case. The patient experienced respiratory distress from February 4 to February 9. He was given glucocorticoid, immunoglobin, antibiotics, antiviral agents, tocilizumab (anti-IL6R), and probiotics, and supplied with oxygen. The respiratory distress symptoms significantly improved from February 11, and the patient was transferred out of the ICU on February 13. SARS-CoV-2 RNA tests on throat swab samples from the patient were negative on February 12 and 14, and he was discharged from hospital on February 20. After discharge, the patient remained in quarantine, and was tested for SARS-CoV-2 RNA every three days. A throat swab sample from the patient was again positive for SARS-CoV-2 RNA on March 5 (Fig.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The neuroinvasive nature of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) allows it to invade the brain through both the olfactory route and the vagus nerve, which may be an important mechanism for causing clinical symptoms such as early olfactory loss, gastrointestinal and respiratory dysfunctions in COVID-19 patients.270,271”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [270]
Experimental — accuracy not yet measuredIn the citing paper
“Moreover, even when respiratory testing for SARS-CoV-2 yields negative results, viral RNA can still be detected in faeces, indicating persistence and replication of SARS-CoV-2 within the gastrointestinal tract.270”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [270]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Evidence for gastrointestinal infection of SARS-CoV-2
Xiao, F., Tang, M., Zheng, X., Liu, Y., Li, X., & Shan, H. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.055 · Cited by 2,836
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., & Tian, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0402-2 · Cited by 1,768
SARS-CoV-2 productively infects human gut enterocytes
Lamers, M. M., Beumer, J., van der Vaart, J., Knoops, K., Puschhof, J., Breugem, T. I., Ravelli, R. B. G., Paul van Schayck, J., Mykytyn, A. Z., Duimel, H. Q., et al. (2020) · Science · doi:10.1126/science.abc1669 · Cited by 1,573 · cited 2×
“…l k i j h f d b a a9 a6 a4 a0 y x w vu t rs q p nm o a3 z a2a1 a5 a8 a7 ce g p:__Verrucom icrobia p:__Verrucom icrobiae p__proteobacteria c__ Ery sip elo tric hi c__Deltadroteobacteria © The Author(s) 2020 233 P ro te in & C e ll to be susceptible to SARS-CoV2 infection (Lamers et al., 2020).”
Prolonged presence of SARS-CoV-2 viral RNA in faecal samples
Wu, Y., Guo, C., Tang, L., Hong, Z., Zhou, J., Dong, X., Yin, H., Xiao, Q., Tang, Y., Qu, X., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30083-2 · Cited by 1,547
Xu, Y., Li, X., Zhu, B., Liang, H., Fang, C., Gong, Y., Guo, Q., Sun, X., Zhao, D., Shen, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0817-4 · Cited by 1,415
Self-citationPositive RT-PCR test results in patients recovered from COVID-19
Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., & Xu, H. (2020) · JAMA · doi:10.1001/jama.2020.2783 · Cited by 1,251
Wang, J., Li, F., Wei, H., Lian, Z.-X., Sun, R., & Tian, Z. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140625 · Cited by 490
COVID-19: a new challenge for human beings
Yang, P., & Wang, X. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0407-x · Cited by 452
Self-citation
Cited by
Potential intestinal infection and faecal–oral transmission of SARS-CoV-2
Guo, M., Tao, W., Flavell, R. A., & Zhu, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00416-6 · Cited by 304
Self-citationWu, Y., Cheng, X., Jiang, G., Tang, H., Ming, S., Tang, L., Lu, J., Guo, C., Shan, H., & Huang, X. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00232-5 · Cited by 204
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“270,271 Autopsy evidences from COVID-19 patients directly demonstrated that SARS-CoV-2 enters the CNS partly through the olfactory mucosal-nervous milieu.”
Self-citationTao, W., Zhang, G., Wang, X., Guo, M., Zeng, W., Xu, Z., Cao, D., Pan, A., Wang, Y., Zhang, K., et al. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100023 · Cited by 167
“All laboratory procedures for clinical samples have been previously reported [12,14,15].”
MethodSelf-citationJiang, G., Wu, J., Weidhaas, J., Li, X., Chen, Y., Mueller, J. F., Li, J., Kumar, M., Zhou, X., Arora, S., et al. (2022) · Water Research · doi:10.1016/j.watres.2022.118451 · Cited by 88
“It is known that COVID-19 patients continue to shed virus even after recovery of symptoms (Sun et al., 2020; Tao et al., 2021; Wu et al., 2020a).”
Metadata
- Authors
- Tao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., Wang, Y., Weng, J., Ma, X., Jin, T., & Zhu, S.
- Affiliations
- University of Science and Technology of China (CN)
- Anhui Provincial Center for Disease Control and Prevention (CN)
- Corresponding author
- Ma, Xiaoling
- Jin, Tengchuan
- Zhu, Shu
- ORCID
- Venue
- Protein & Cell
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-09-26
- Volume
- 12
- Issue
- 3
- Pages
- 230-235
- ISSN
- 1674-800X (ISSN-L)
- 1674-8018
- PMC
- PMC7518948
- OpenAlex
- W3088501530
- Cited by
- 42
- References
- 15
- Citations by year
- 2025: 1 · 2023: 7 · 2022: 12 · 2021: 19 · 2020: 3
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Protein & Cell (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31770990, #81821001, 81822021, COVID-19, 91842105)
- Chinese Academy of Sciences (XDB29030101)
- University of Science and Technology of China
- Fundamental Research Funds for the Central Universities (YD9110002001, WK2070000159)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- SARS-CoV-2, COVID-19 pandemic, intestinal infection, gastrointestinal symptoms, RT-PCR, viral persistence, convalescent patients, anal swab, nasopharyngeal swab, quarantine, reinfection risk, close contacts, SARS-CoV-2 RNA
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Antibodies, Viral, Feces, Female, Humans, Intestines, Male, RNA, Ribosomal, 16S, RNA, Viral
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. https://app.cochat.ai/papers/10.1007/s13238-020-00778-8
- The paper
- Tao, W., Wang, X., Zhang, G., Guo, M., Ma, H., Zhao, D., Sun, Y., He, J., Liu, L., Zhang, K., Wang, Y., Weng, J., Ma, X., Jin, T., & Zhu, S. (2021). Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein & Cell. https://doi.org/10.1007/s13238-020-00778-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.